Statin and Serotonin Ligands for Host Cell Protein Yield
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing biological molecules, such as therapeutic, prophylactic, and diagnostic proteins, in host cells often result in sub-optimal yields, with existing strategies showing limited effectiveness in increasing production efficiencies and maintaining product purity for commercial-scale manufacturing.
Innovation Solution
Modulation of cellular pathways, specifically through the use of statin-associated and serotonin receptor signaling pathways, using compounds like statins and serotonin receptor ligands at low concentrations to enhance protein and viral particle production in host cell systems, including cell cultures and embryonated eggs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional host cell systems are used for producing biological molecules, then production can be maintained with standard processes, but yield remains sub-optimal and production efficiency is limited
Solution Approach 1:
The patent applies parameter changes by modifying cellular pathways through chemical compounds. Specifically, it uses statin compounds to inhibit HMG-CoA reductase and serotonin receptor ligands to modulate signaling pathways, thereby changing the biochemical parameters within host cells to enhance protein and viral particle production without fundamentally altering the manufacturing process
2Productivity
If existing strategies to increase production are implemented, then some yield improvement is achieved, but effectiveness is limited and product purity may be compromised
Solution Approach 1:
The patent uses chemical compounds as intermediaries to mediate between the host cell's natural processes and the desired production enhancement. Statin compounds and serotonin receptor ligands act as intermediaries that selectively modulate cellular pathways, enabling yield improvement while maintaining product purity through controlled, specific pathway interactions rather than粗放式 production enhancement
3Productivity
If small molecule compounds are used to modulate cellular pathways, then production yield increases 2- to 10-fold, but additional process parameters must be controlled
Solution Approach 1:
The patent employs parameter changes by introducing small molecule compounds that specifically target and modify cellular pathway parameters. The use of statins and serotonin receptor ligands allows for controlled modification of metabolic and signaling parameters, achieving 2- to 10-fold yield increases while the specific nature of these compounds allows for relatively straightforward process control compared to more complex intervention strategies
Data Source
AI summary
Disclosed herein are methods for increasing protein yield and cellular productivity. Chemical agents facilitate host cell production of biological molecules to increase product yield.